A drug that appears to make memories of fearsome events less durable in mice has been discovered by researchers. The finding may accelerate the development of treatments for preventing PTSD. The drug, called osanetant, targets a distinct group of brain cells in a region of the brain that controls the formation and consolidation of fear memories.